Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0370220170610060301
Yakhak Hoeji
2017 Volume.61 No. 6 p.301 ~ p.308
A Comparative Analysis on the Labeling System of Non-prescription drug¡¯s outer packaging in Korea, United States and Europe: Focusing on the Legibility factors
Yang Jin-Wook

Kwon Kyeng-Hee
Abstract
Labeling of non-prescription medicines should be legible and clear, and should be written with the consumer's readability in mind so that the consumer can take proper action. In this study, we compared and analyzed the regulatory labeling system and factors applied in the non-prescription drugs¡¯ outer packaging, focusing on the legibility as one of the elements of readability. Although the domestic regulations have been improved to a considerable extent as a result of various studies to improve the system until recently, it is still not enough in terms of the detailed standards as compared with the overseas guidelines. In particular, the United States provides a detailed guide by applying the standard format design called Drug Facts. In Europe, the labeling guidelines are not concrete, but basically the notion of readability implies that the consumer is required to make the information easy to read and understand. Europe also has a pre-approval system of packaging and attached documents in the pre-market stage to ensure that consumers are provided with readable drug information. However, there may be a gap between regulation and the real products so it is necessary to design delicate regulations so that it can be applied to products well. Also, even if a consistent format is presented, it will be possible to achieve the improvement only when education on how to read and use the labeling of non-prescription drugs is supported.
KEYWORD
medicines, labeling, readability, legibility
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)